Early-phase clinical trial data published in the New England Journal of Medicine (2023) demonstrated significant reductions in body weight and improvements in metabolic markers
That role has to fall to something else: clinical review, nutritional guidance, behavioural support, ongoing monitoring, practical self-management tools, or a combination of these
Taken weekly, premium GLP-1 is the active ingredient in medicines used to treat type 2 diabetes and treat obesity
Tirzepatide (Zepbound and Mounjaro) hits 2 targets - the GLP1 and GIP receptors - and works even more effectively than semaglutide at controlling blood sugar and helping with weight loss
Excess adiposity and its many complications, including cardiovascular diseases, type 2 diabetes and cancer, are the main factors of global morbidity and mortality and have a negative impact on health systems
You may want to ask which specific pharmacy will fill your prescription when you sign up